CII
MTEM

CR Intrinsic Investors’s Molecular Templates, Inc. MTEM Stock Holding History

CR Intrinsic Investors’s Portfolio MTEM Stock Details MTEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-2,753
Closed -$2.11M – 382
2013
Q3 		$2.11M Buy
+2,753
New +$2.26M 0.07% 289

Other funds holding MTEM

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CR Intrinsic Investors's MTEM Position: Q4 2013 in Review

CR Intrinsic Investors sold out of Molecular Templates, Inc. (MTEM) in Q4 2013, closing a stake of 2,753 shares — an estimated $2.11M sold.

CR Intrinsic Investors first reported a position in MTEM in Q3 2013 and held it in 1 quarter. The position peaked at $2.11M in Q3 2013. 87 funds tracked by Wall St. Rank hold MTEM as of Q4 2013.

  • CR Intrinsic Investors reported no remaining Molecular Templates, Inc. position as of Q4 2013 after selling out during the quarter.
  • CR Intrinsic Investors sold 2,753 Molecular Templates, Inc. shares in Q4 2013, an estimated $2.11M.
  • CR Intrinsic Investors first reported a position in Molecular Templates, Inc. in Q3 2013 and held it in 1 quarter.
  • CR Intrinsic Investors's Molecular Templates, Inc. position peaked at $2.11M in Q3 2013.
  • 87 funds tracked by Wall St. Rank held Molecular Templates, Inc. as of Q4 2013.

Based on CR Intrinsic Investors's 13F filing for Q4 2013, filed 14 Feb 2014.